Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells

In this study, a transferrin (T(f))-conjugated polymeric nanoparticle was developed for the targeted delivery of the chemotherapeutic agent doxorubicin (Dox) in order to overcome multi-drug resistance in cancer treatment. Our objective was to improve Dox delivery for producing significant antitumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Soe, Zar Chi, Kwon, Jun Bum, Thapa, Raj Kumar, Ou, Wenquan, Nguyen, Hanh Thuy, Gautam, Milan, Oh, Kyung Taek, Choi, Han-Gon, Ku, Sae Kwang, Yong, Chul Soon, Kim, Jong Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410246/
https://www.ncbi.nlm.nih.gov/pubmed/30717256
http://dx.doi.org/10.3390/pharmaceutics11020063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410246/
https://www.ncbi.nlm.nih.gov/pubmed/30717256
http://dx.doi.org/10.3390/pharmaceutics11020063

Ejemplares similares